AG
TWST icon

Aperio Group’s Twist Bioscience TWST Stock Holding History

Aperio Group’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$1.19M Buy
8,435
+2,055
+32% +$228K ﹤0.01% 1494
2020
Q3 		$485K Buy
6,380
+964
+18% +$60K ﹤0.01% 1825
2020
Q2 		$245K Buy
+5,416
New +$194K ﹤0.01% 2105

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
TCM
Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Aperio Group's TWST Position: Q4 2020 in Review

Aperio Group increased its Twist Bioscience (TWST) stake by 32% in Q4 2020, buying an estimated $228K and bringing the position to 8,435 shares worth $1.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1494.

Aperio Group first reported a position in TWST in Q2 2020 and has held it in 3 quarters since. 223 funds tracked by Wall St. Rank hold TWST as of Q4 2020.

  • Aperio Group held 8,435 shares of Twist Bioscience worth $1.19M as of Q4 2020.
  • Aperio Group bought 2,055 Twist Bioscience shares in Q4 2020, an estimated $228K.
  • Twist Bioscience made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #1494 holding.
  • Aperio Group first reported a position in Twist Bioscience in Q2 2020 and has held it in 3 quarters since.
  • 223 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.